Clinical Trials List
Protocol NumberCRFB002D2303
2009-09-01 - 2011-12-31
Phase III
Terminated3
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Shih-Jen Chen Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Chi WU Division of Ophthalmology
- 陳冠任 Division of Ophthalmology
- 陳墩祿 Division of Ophthalmology
- Yih-Shiou Hwang Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
390 participants
